Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

UK BROKER RATINGS: Citigroup Issues Mixed Ratings On Mining Sector

3rd Mar 2014 10:14

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning: ---------- FTSE 100 ---------- BERNSTEIN CUTS RSA INSURANCE PRICE TARGET TO 115 (130) PENCE - 'OUTPERFORM' ---------- CITIGROUP CUTS RSA INSURANCE P Read More

AstraZeneca Gets US Approval For Bydureon Pen

3rd Mar 2014 07:57

LONDON (Alliance News) - AstraZeneca PLC Monday said the US Food and Drug Administration has approved its Bydureon Pen injectable suspension treatment for type 2 diabetes as an adjunct to diet and exercise to improve glycaemic control in adults. In a statement, the drugs giant said that Byd Read More

AstraZeneca Says Orphan Drug MYALEPT Approved By US FDA

25th Feb 2014 18:39

LONDON (Alliance News) - AstraZeneca PLC Tuesday said the US Food and Drug Administration has approved orphan drug MYALEPT as a treatment for fat tissue loss in a rare group of syndromes known as lipodystrophy. The pharma company said the approval is for MYALEPT as an adjunct to diet as rep Read More

MARKET COMMENT: UK Stocks Lose Momentum Ahead Of FOMC Minutes

19th Feb 2014 16:53

LONDON (Alliance News) - UK stocks have struggled to get off the ground Wednesday, closing broadly unchanged despite some impressive individual stock performances. The FTSE 100 initially opened higher, continuing a rally that has seen the index retrace most of January's losses. However, after bre Read More

UK Dividends Calendar - Week Ahead

19th Feb 2014 06:16

UK Dividends Calendar - Week Ahead

18th Feb 2014 16:04

UK Dividends Calendar - Week Ahead

18th Feb 2014 06:12

UK Dividends Calendar - Week Ahead

17th Feb 2014 16:16

UK Dividends Calendar - Week Ahead

14th Feb 2014 16:03

UK Dividends Calendar - Week Ahead

14th Feb 2014 06:29

UK Dividends Calendar - Week Ahead

13th Feb 2014 16:12

UK BROKER RATINGS: Panmure Raises Shire Price Target 15%

13th Feb 2014 10:11

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday afternoon: ---------- FTSE 100 ---------- GOLDMAN CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3408 (3420) PENCE - 'BUY' ---------- Read More

UK Dividends Calendar - Week Ahead

13th Feb 2014 06:15

UK Dividends Calendar - Week Ahead

12th Feb 2014 16:12

DIRECTOR DEALINGS: AstraZeneca Chairman Buys 4,500 Shares

12th Feb 2014 16:10

LONDON (Alliance News) - AstraZeneca PLC Wednesday said Chairman Leif Johansson bought 4,500 shares at a price of SEK422.56 per share. Following this transaction, Johansson has a total interest in 33,009 AstraZeneca shares. Shares in the pharmaceutical company were up 0.5% at 3,994.50 Read More

UK MIDDAY BRIEFING: UK Interest Rates To Stay Low For Some Time

12th Feb 2014 13:46

LONDON (Alliance News) - Bank of England Governor Mark Carney Wednesday said the central bank still thinks interest rates will have to remain where there are for some time for come, as he changed the bank's trigger for discussing rate rises to the takeup of "spare capacity" in the economy rath Read More

TOP NEWS: Bank Of England Governor Says Rates Need To Stay Low

12th Feb 2014 11:20

LONDON (Alliance News) - The following is a summary of top news stories Wednesday. ---------- COMPANIES ---------- Tullow Oil PLC said its pretax profit fell significantly in its recent full year, due to lower disposal gains and higher expl Read More

UK MORNING BRIEFING: Telecity Drops 13% As Market Awaits BOE

12th Feb 2014 08:25

LONDON (Alliance News) - Shares have opened mostly flat Wednesday, as the market awaits the Bank of England's Quarterly Inflation Report at 1030 GMT. Telecity is holding back the FTSE 250. The data-centre provider is down 13% after announcing higher 2013 profit and Read More

FDA Seeks Clinical Trial Data From AstraZeneca On Diabetes Drug Saxagliptin

12th Feb 2014 06:49

LONDON (Alliance News) - The US Food and Drug Administration has requested clinical trial data from AstraZeneca PLC., the manufacturer of saxagliptin, to investigate a possible association between use of the type 2 diabetes drug and heart failure. The request follows a study published in th Read More

DIRECTOR DEALINGS: AstraZeneca Non-Executive Buys Shares

11th Feb 2014 17:10

LONDON (Alliance News) - AstraZeneca PLC Tuesday said non-executive Director Graham Chipchase bought 400 shares at a price of 3839 pence per share. Following this transaction, Chipchase holds 1,900 shares. Shares in the pharmaceutical company closed up 1.5% at 3,974.50 pence Tuesday.< Read More

FTSE 100 Latest

Value10,138.09

Change0.00